Monthly Archives: January 2013

Targeted Medical Pharma Receives Notice of Issuance for Comprehensive Billing Patent

Los Angeles, January 30, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced it has received an Issue Notification from the United States Patent and Trademark Office (USPTO) regarding projected patent number 8370172, which relates to a system and method for submitting claims for a dispensed medication to a patient by point-of-care physicians. The USPTO indicated that it expects the patent will be issued on February 5th, 2013. Continue reading →

Five Targeted Medical Pharma Products Listed on U.S. Dept. of Veterans Affairs’ Federal Supply Schedule (FSS)

–Company’s Prescription-Only Medical Foods Now Available for Purchase by Federal Agencies through FSS– Los Angeles, January 7, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that five of its core prescription-only medical foods are now listed on the U.S. Department of Veterans Affairs’ Federal Supply Schedule (FSS). The Company’s designated products are listed under the FSS category 65IB: Drugs, Pharmaceuticals and Hematology products. The listed products that Continue reading →